Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- Status
- RECRUITING
- Phase
- PHASE3
Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3